Ειδήσεις: STRUCTURE THERAPEUTICS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

22/03 22:26 yahoo.com

Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges

Structure Therapeutics shares decline stake biotech market volatility

19/03 09:02 defenseworld.net

Structure Therapeutics Posts 15%+ Weight Loss in ACCESS II for Oral GLP-1 Aleniglipron, Eyes Phase III

aleniglipron GLP‑1 agonist weight loss Structure Therapeutics ACCESS II oral therapy

19/03 07:32 defenseworld.net

HC Wainwright Has Positive Forecast for GPCR FY2027 Earnings

HC Wainwright Structure Therapeutics GPCR earnings forecast EPS buy rating

17/03 08:20 defenseworld.net

Structure Therapeutics (NASDAQ:GPCR) Price Target Cut to $100.00 by Analysts at HC Wainwright

Structure Therapeutics price target HC Wainwright Guggenheim Stifel Nicolaus Weiss Ratings

16/03 15:18 statnews.com

STAT+: Pharmalittle: We’re reading about obesity pill trial results, cholesterol guidelines, and more

Obesity Weight Loss Structure Therapeutics Clinical Trial Cholesterol Guidelines Medication

16/03 13:57 statnews.com

STAT+: Structure reports significant weight loss from mid-stage GLP-1 pill

GLP‑1 obesity pill weight loss Structure Therapeutics Lilly Novo Nordisk

16/03 13:57 statnews.com

STAT+: Structure reports significant weight loss from mid-stage GLP-1 pill

GLP‑1 obesity pill weight loss Structure Therapeutics Lilly Novo Nordisk

Loading...